The impact of statin treatment duration on the risk of new-onset diabetes mellitus and recurrent vascular events in ischemic stroke patients: a linked data analysis.
Tae Jung KimJi Sung LeeJae Sun YoonMi Sun OhJi-Woo KimSoo-Hyun ParkKyung-Ho YuByung-Chul LeeSang-Bae KoByung-Woo YoonPublished in: Cerebrovascular diseases (Basel, Switzerland) (2024)
Statin therapy following ischemic stroke increased the occurrence of NODM in patients over a period of 3 years. Despite the increased risk of NODM, statin therapy shows a beneficial effect in reducing major cardiovascular events such as recurrent ischemic stroke and AMI in patients with ischemic stroke.
Keyphrases
- cardiovascular events
- end stage renal disease
- coronary artery disease
- cardiovascular disease
- newly diagnosed
- data analysis
- atrial fibrillation
- ejection fraction
- peritoneal dialysis
- left ventricular
- adipose tissue
- patient reported outcomes
- mesenchymal stem cells
- acute coronary syndrome
- replacement therapy
- glycemic control